KARA JAEGER: Open Payments
NPI 1932882446 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 15 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $1,032 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $171 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Ozempic, AIRSUPRA, Cologuard Collection Kit, GARDASIL 9, CAPLYTA, Wegovy, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
